Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: interim results of a multicenter compassionate use program

Welzel TM, Herzer K, Ferenci P, Petersen J, Gschwantler M, Cornberg M, et al. Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: interim results of a multicenter compassionate use program. 50th Annual Meeting of the European Association for the Study of the Liver (EASL). 2015;:S619.

Publication Type:

Journal Article

Source:

50th Annual Meeting of the European Association for the Study of the Liver (EASL), p.S619 (2015)

Keywords:

Disease, HCV, Liver, Patients, Ribavirin, sofosbuvir, treatment

Notes:

Vienna, Austria
Top